Company chart and information is provided by TradingView based on 15-minute-delayed data.
I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company's product pipeline includes TJ202, TJ301, TJ107, TJC4, TJD5, and TJM2.
| Website: | www.i-mabbiopharma.com |
| Main Phone: | +86 2160578000 |
| Address: | 88 Shangke Road |
| Address 2: | Suite 802, West Tower, OmniVision |
| City / Town: | Shanghai |
| Country: | CN |
| Postal Code: | 201210 |
| Exchange: | NSD |
| CEO: | Joan Huaqiong Shen |
| Employees: | 185 |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
